News Releases

These are news releases that are related to our Investor efforts.  Releases are listed in chronological order and are archived by year.  Sign-up to receive news as it is released using the email and RSS tools below.

Investor Alerts

Year All Years 2018 2017 Keywords Go

Advanced Search

Search

  Search Headlines Only

From

To

Asset Types

 Photos  Video  Audio  Documents  Events  Standard

 Basic Search

• Nov 7, 2018

  Achieve Reports Financial Results for Third Quarter 2018 and Provides Cytisinicline (Cytisine) Clinical Development Update
• Oct 31, 2018

  Achieve Life Sciences to Announce Third Quarter 2018 Financial Results and Host Conference Call and Webcast on November 7, 2018
• Oct 30, 2018

  Achieve Life Sciences Announces Initiation of Phase 2b ORCA-1 Trial Evaluating Cytisinicline (cytisine) for Smoking Cessation
• Oct 1, 2018

  Achieve Announces Pricing of $5.6 Million Registered Direct Offering
• Sep 27, 2018

  Achieve Announces Results of Clinical Study Demonstrating Similar Bioavailability for a New Cytisine Formulation in Fed and Fasted Subjects
• Sep 26, 2018

  Achieve to Present at the Ladenburg Thalmann 2018 Healthcare Conference on October 2, 2018
• Sep 18, 2018

  Achieve Announces Positive Cytisine Data Published in International Journal of Drug Policy

  Cytisine Demonstrated Superior Abstinence Rates Compared to Nicotine Replacement Therapy
• Sep 6, 2018

  Achieve Life Sciences Announces Cytisine Data Presented at the Society for Research on Nicotine and Tobacco Europe (SRNT-E) Annual Conference
• Sep 5, 2018

  Achieve to Present at the H.C. Wainwright 20th Annual Global Investment Conference on September 6, 2018
• Aug 8, 2018

  Achieve Reports Financial Results for Second Quarter 2018 and Provides Cytisine Clinical Development Update

Show 5102550100 per page